English (UK)
中文版yanfei zhou
ZhongXi Capital focus on biomedical investment，fiancing，consulting and other capital market business.
ZhongXi Capital
高级投资经理Min Zhou
Hainan Haiyao, a Chinese public company with stock code of 000566, is established in 1965, mainly focused on some severe diseases such as infection, tumor, digestion system etc.
Hainan Haiyao Co. , Ltd
BD DirectorIvy Zhou
Shenzhen Beimei Pharma is focused in the field of pediatric prescription drugs, and aims to become a new-styled pharmaceutical company integrated with R&D, in-licensing, production and sales. It takes independent R&D and the in-licensing of domestic and international pediatric products as its strategic direction. The current product pipeline covers the respiratory, anti-infection (antibacterial), neuroscience, gastroenterology and others. Beimei Pharma is committed to providing Chinese pediatric patients with convenient, accurate, excellent-taste and high-quality products.
Shenzhen Beimei Pharmaceutical Co. Ltd.
Head of Business DevelopmentKaiqi Zhou
Top medical device company in China focused on cardiovascular, surgical robotics and ten more fields.
Shanghai MicroPort Medical
BD AssociateMonica Zhou
Established in Shenzhen Special Economic Zone in 1992;
Core competitiveness - A specialty company in digestion and intestinal microecology and a national level Hi-tech Enterprise.
Core competitiveness - A specialty company in digestion and intestinal microecology and a national level Hi-tech Enterprise.
Shenzhen Wanhe Pharma
BDJames Zhou
A biotech company headquartered in China with clinically validated integrated platform for drug discovery and development. We focus on oncology and inflammatory disease. There are four projects on Phase I clinical stage.
Responsive Web Design powered by 